S. pneumoniae antigens

Details S. pneumoniae antigens S. pneumoniae antigens

2004-04-15

2009-12-22

Mondesi, Robert B (Department: 1645)

Drug, bio-affecting and body treating compositions

Antigen, epitope, or other immunospecific immunoeffector

Bacterium or component thereof or substance produced by said...

C424S184100, C530S300000, C530S350000, C435S069100, C435S069700, C435S320100, C536S023100, C536S023700

Reexamination Certificate

active

07635487

ABSTRACT:
The present invention discloses isolated nucleic acid molecules encoding a hyperimmune serum reactive antigen or a fragment thereof as well as hyperimmune serum reactive antigens or fragments thereof fromS. pneumoniae, methods for isolating such antigens and specific uses thereof.

REFERENCES:
patent: 4946778 (1990-08-01), Ladner et al.
patent: 5849902 (1998-12-01), Arrow et al.
patent: 5989912 (1999-11-01), Arrow et al.
patent: 6951652 (2005-10-01), Porro
patent: A 1924/2001 (2003-06-01), None
patent: 2045869 (1991-12-01), None
patent: 197 42 706 (1999-04-01), None
patent: A-O 464 533 (1992-01-01), None
patent: 0 533 838 (1993-03-01), None
patent: 02/05448 (2002-01-01), None
patent: WO 02/77021 (2002-03-01), None
patent: 98/08856 (1998-03-01), None
patent: 99/38528 (1999-08-01), None
patent: 01/54720 (2001-02-01), None
patent: 01/24822 (2001-04-01), None
patent: 01/93903 (2001-12-01), None
patent: 01/93905 (2001-12-01), None
patent: 02/13857 (2002-02-01), None
patent: 02/32451 (2002-04-01), None
patent: WO 02/059148 (2002-08-01), None
patent: 97/30721 (2007-03-01), None
Mc Cool (J Exp Med. Feb. 4, 2002;195(3):359-65).
J Exp Med. Feb. 4, 2002;195(3):359-65.
Ellis, R.W. (Chapter 29 of “Vaccines” Plotkin, 5.A. et al. (eds) published by W. B. Saunders company (Philadelphia) in 1988, pp. 568-575.
Accession No. ABU02747.
US 5,744,309, (withdrawn).
Adamou, J., et al. (2001). “Identification and Characterization of a Novel Family of Pneumococcal Proteins That Are Protective against Sepsis” Infect Immun 69: 949-58.
Altschul, S., et al. (1990). “Basic Local Alignment Search Tool” Journal of Molecular Biology 215: 403-10.
Bennett, D., et al. (1995). J Mol Recognit 8: 52-8.
Brown, J., et al. (2001). “Immunization with Components of Two Iron Uptake ABC Transporters Protects Mice against SystemicStreptococcus pneumoniaeInfection” Infect Immun 69: 6702-6.
Burnie, J., et al. (1998). “The renaissance of antibody therapy” J Antimicrob Chemother 41: 319-22.
Clackson, T., et al. (1991). Nature 352: 624-8.
Devereux, J., et al. (1984). “A comprehensive set of sequence analysis programs for the VAX” Nucleic acids research 12: 387-95.
Di Guilmi, A., et al. (2002). “New approaches towards the identification of antibiotic and vaccine targets inStreptococcus pneumoniae” EMBO Reports 3: 728-34.
Doherty, E., et al. (2001). Annu Rev Biophys Biomol Struct 30: 457-475.
Eisenbraun, M., et al. (1993). DNA Cell Biol 12: 791-7.
Wizemann, T., et al. (2001). “Use of a Whole Genome Approach To Identify Vaccine Molecules Affording Protection againstStreptococcus pneumoniaeInfection” Infect Immun 69: 1593-8.
Etz, H., et al. (2001). “Bacterial Phage Receptors, Versatile Tools for Display of Polypeptides on the Cell Surface” J Bacteriol 183: 6924-35.
Ganz, T. (1999). “Defensins and Host Defense.” Science 286: 420-421.
Georgiou, G. (1997). “Display of heterologous proteins on the surface of microorganisms: From the screening of combinatorial libraries to live recombinant vaccines” Nature Biotechnology 15: 29-34.
Gray, B., et al. (1979). J Infect Dis 140: 979-83.
Gray, B., et al. (1986). Pediatr Infect Dis 5: 201-7.
Hashemzadeh-Bonehi, L., et al. (1998). Mol Microbiol 30: 676-678.
Hausdorff, W., et al. (2001). “Geographical differences in invasive pneumococcal disease rates and serotype frequency in young children” Lancet 357: 950-2.
Tettelin, H., et al. (2001). Science 293: 498-506.
Hemmer, B., et al. (1999). “Identification of candidate T-cell epitopes and molecular mimics in chronic Lyme disease” Nat Med 5: 1375-82.
Hoe, N., et al. (2001). “Distribution of Streptococcal Inhibitor of Complement Variants in Pharyngitis and Invasive Isolates in an Epidemic of Serotype M1 Group AStreptococcusInfection” J Infect Dis 183: 633-9.
Hornef, M., et al. (2002). “Bacterial strategies for overcoming host innate and adaptive immune responses” Nat Immunol 3: 1033-40.
Hoskins, J., et al. (2001). “Genome of the BacteriumStreptococcus pneumoniaeStrain R6” J Bacteriol 183: 5709-17.
Hyde, T., et al. (2001). “Macrolide Resistance Among InvasiveStreptococcus pneumoniaeIsolates” JAMA 286: 1857-62.
Jedrzejas, M. (2001). Microbiol Mol Biol Rev 65: 187-207.
Johanson, K., et al. (1995). “Binding Interactions of Human Interleukin 5 with Its Receptor Subunit” J Biol Chem 270: 9459-71.
Jones, P., et al. (1986). “Replacing the complementarity-determining regions in a human antibody with those from a mouse” Nature 321: 522-5.
Kajava, A., et al. (2000). “The Net Charge of the First 18 Residues of the Mature Sequence Affects Protein Translocation across the Cytoplasmic Membrane of Gram-Negative Bacteria” J Bacteriol 182: 2163-9.
Kohler, G., et al. (1975). “Continuous cultures of fused cells secreting antibody of predefined specificity” Nature 256: 495-7.
Kolaskar, A., et al. (1990). “A semi-empirical method for prediction of antigenic determinants on protein antigens” FEBS Lett 276: 172-4.
Lewin, A., et al. (2001). “Ribozyme gene therapy: applications for molecular medicine” Trends Mol Med 7: 221-8.
Marks, J., et al. (1992). Biotechnology (N Y) 10: 779-83.
McCafferty, J., et al. (1990). Nature 348: 552-4.
McCormick, A., et al. (2003). “Geographic diversity and temporal trends of antimicrobial resistance inStreptococcus pneumoniaein the United States” Nat Med 9: 424-30.
McDaniel, L., et al. (1991). “PspA, a surface protein ofStreptococcus pneumoniae, is capable of eliciting protection against pneumococci of more than one capsular type” Infect Immun 59: 222-8.
Navarre, W., et al. (1999). Microbiol Mol Biol Rev 63: 174-229.
Okano, H., et al. (1991). J Neurochem 56: 560-7.
Tourdot, S., et al. (2000). “A general strategy to enhance immunogenicity of low-affinity HLA-A2.1-associated peptides: implication in the identification of cryptic tumor epitopes” Eur J Immunol 30: 3411-21.
Orange, M., et al. (1993). Pediatr Infect Dis J 12: 244-6.
Pelton, S., et al. (2003). “Pneumococcal conjugate vaccines: proceedings from an Interactive Symposium at the 41st Interscience Conference on Antimicrobial Agents and Chemotherapy” Vaccine 21: 1562-71.
Phillips-Quagliata, J., et al. (2000). “The IgA/IgM Receptor Expressed on a Murine B Cell Lymphoma Is Poly-Ig Receptor” J Immunol 165: 2544-55.
Rammensee, H., et al. (1999). “SYFPEITHI: database for MHC ligands and peptide motifs” Immunogenetics 50: 213-9.
Roche, H., et al. (2003). “Regions of PspA/EF3296 Best Able To Elicit Protection againstStreptococcus pneumoniaein a Murine Infection Model” Infect Immun 71: 1033-41.
Romero-Steiner, S., et al. (1999). “Reduction in Functional Antibody Activity AgainstStreptococcus pneumoniaein Vaccinated Elderly Individuals Highly Correlates with Decreased IgG Antibody Avidity” Clin Infect Dis 29: 281-8.
Rosenow, C., et al. (1997). “Contribution of novel choline-binding proteins to adherence, colonization and immunogenicity ofStreptococcus pneumoniae” Mol Microbiol 25: 819-29.
Seeger, C., et al. (1984). “The Cloned Genome of Ground Squirrel Hepatitis Virus is Infectious in the Animal” Proc Natl Acad Sci U S A 81: 5849-52.
Shibuya, A., et al. (2000). “Fc receptor mediates endocytosis of IgM-coated microbes” Nature Immunology 1: 441-6.
Sekrra, A. et al. (1994). “Use of the tetracycline promoter for the tightly regulated production of a murine antibody fragment inEscherichia coli” 151: 131-5.
Talkington, D. et al (1996) Microb Pathog 21: 17-22.
Tang, D., et al. (1992). Nature 356: 152-4.

Affiliated with

Also associated with

Rating

S. pneumoniae antigens does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with S. pneumoniae antigens, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and S. pneumoniae antigens will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4057602